- Home
- CTRM vs SCNX Comparison
CTRM vs SCNX Comparison
Compare CTRM & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CTRM | SCNX |
|---|---|---|
| Founded | 2016 | 2010 |
| Country | Cyprus | United States |
| Employees | N/A | 19 |
| Industry | Marine Transportation | Other Pharmaceuticals |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.2M | 19.0M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | CTRM | SCNX |
|---|---|---|
| Price | $1.93 | $0.39 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.50 |
| AVG Volume (30 Days) | 40.6K | ★ 320.3K |
| Earning Date | 04-15-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $1,097.38 |
| Revenue Next Year | N/A | $239.80 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.66 | $0.24 |
| 52 Week High | $2.65 | $2.60 |
Technical Indicators
Market Signals| Indicator | CTRM | SCNX |
|---|---|---|
| Relative Strength Index (RSI) | 48.87 | 48.47 |
| Support Level | $1.85 | $0.37 |
| Resistance Level | $2.17 | $0.47 |
| Average True Range (ATR) | 0.08 | 0.03 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 26.92 | 17.51 |
Price Performance
Historical ComparisonAbout CTRM Castor Maritime Inc.
Castor Maritime Inc is a provider of seaborne transportation services for dry bulk cargo, including iron ore, coal, grain, steel products, fertilizers, cement, bauxite, sugar, and scrap metal, among others. The firm operates under three reportable segments namely (i) the dry bulk segment (ii) the containership segment and (iii) the asset management segment. It generates maximum revenue from the Dry bulk segment.
About SCNX Scienture Holdings Inc.
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.